Foreign traders shocked and paralyzed as TASE trading fails to open at usual time because of strife between union, management ■ Trading set to open 1:15 P.M. Israel time ■ Union spokesman denies strike, blames CEO for cutting staff
Legendary investor had 3.9% stake in drug marker at end of first quarter
The drug maker not only faces price-fixing allegations in the U.S. but also is a party to a suit on opiod abuse
The offer sends shares of the beleaguered telecoms group soaring
The cellular company may need a capital infusion and that could upset the IDB group’s delicate debt position
Bank sets aside another $246 million to cover costs of U.S. tax probe
Israeli stock market had been closed since attorney general announced he intends to indict the prime minister
TASE getting another medical marijuana firm ■ Secondary bourse could begin in 2020 ■ Warburg brings in three partners as it completes acquisition of Leumi Card ■ Securities Authority to focus on making Israeli market more attractive to investors
Mega Or and Big Shopping Centers make last-minute bid to buy company’s chief asset, pushing out Moti Ben-Moshe
Securities investigators raid five companies on fraud, insider-trading suspicions ■ Day ends with mild losses
After year’s wait, KLA-Tencor’s acquisition of Orbotech to be completed Wednesday ■ U.S. hedge fund Starboard sells Mellanox stock at big profit ■ Tel Aviv shares eke out gain in thin trading
The growing number of shares trading on the Tel Aviv Stock Exchange have soared based mostly on investors’ inchoate hopes – not on fundamentals
Tel Aviv shares mark their fifth rise in last six sessions ■ Buffet’s Berkshire Hathaway sees Teva holding lose $264 million in value ■ Ratio Petroleum soars on start of Guyana oil exploration ■ Plus500 admits to typo that misled investors about losses
Plantext to be first Israeli cannabis company to be traded overseas ■ Stanley Fischer hired to advise BlackRock ■ Wall Street weighs down Tel Aviv shares
Tel Aviv shares end higher, despite Teva Pharmaceuticals selloff ■ Bondholders backing alternative to Africa Properties
Israeli drug maker sees a repeat this year of the tough market conditions of 2018
Latest Africa Israel bailout proposal fails ■ Internet Gold edges to liquidation after failing to get improved offer for B Com
Paz Oil building power plant ■ Stocks fall as Israel Chemicals tumbles
Coca-Cola Israel bids on South African food firm Clover ■ TASE stays basically unchanged
Teva migraine drug fails to win coverage by major pharma benefit manager ■ S&P affirms Israel’s credit rating despite fiscal setbacks
Shari Arison reaches deal to sell Miya water business for $260 million ■ Group including U.S. investors puts $50m into Israeli energy firm Givot Olam
Tel Aviv shares gain as volume picks up ■ CEO of grocery chain Tiv Taam loses job in dispute with founder ■ Three bidders emerge in sale of Israir
Tiv Tam CEO put on leave after dispute with ex-father-in-law boss ■ B Communications sells shares in bid to avoid bailout
The latest effort by Internet Gold to sell control of Israel's largest telecommunications yields no buyers as foreign investors weigh down the company's stocks
Shari Arison sells Israeli salt monopoly to Fortissimo fund ■ Five companies weighing bids to set up small-business lender
Meanwhile state-owned Israel Aerospace Industries is in talks to invest in drone maker Aeronautics
Teva said to be in talks to sell Oncotest diagnostics unit ■ Africa Israel bailout collapses as Moti Ben-Moshe asks for deposit back
Securities regulator issues warning on investing in speculative shares
Migdal CEO reassures employees after chairman’s departure ■ Victory supermarket chain owner questioned on price fixing suspicions
In any case, Israel is ready for a crisis, with a relatively low budget deficit and huge foreign reserves